When Sem Lampotang, PhD, was diagnosed with prostate cancer, even a traditional biopsy came back negative. When UF Health urologic oncologist Dr. Li-Ming Su noticed that Sem’s prostate-specific antigen levels continued to rise, Dr. Su recommended using a new MRI-fusion biopsy technology for a second sample. Unlike conventional prostate biopsies, the MRI-fusion technology acts as a GPS to navigate the biopsy needle to the exact tumor location in order to extract a sample. Through this technique, Sem’s biopsy came back positive for prostate cancer. With the guidance and support of his clinical team, Sem opted for prostate cancer surgery, known as robotic-assisted laparoscopic prostatectomy, where his tumor was successfully removed. Now, Sem is back to his hobby of swimming laps. Only this time, he’s a bit faster.